Intolerance to Casein Hydrolysate Formula:Clinical Aspects
Intolerance to Casein Hydrolysate Formula:Clinical Aspects
复制标题
对酪蛋白水解产物配方的不耐受:临床方面
DOI:
--
复制
发表时间:
1991
期刊:
影响因子:
--
通讯作者:
S. Freier
中科院分区:
文献类型:
--
作者:
E. Rosenthal;Yechiel Schlesinger;Y. Birnbaum;R. Goldstein;A. Benderly;S. Freier
Infant A. P. was fed Materna", a modified cow's milk formula (Maabaroth Pharmaceutical Products, Kibbutz Maabaroth, Israel) from birth. At two weeks she was admitted because of diarrhoea for 10 days. Stool cultures were negative. Cow's milk intolerance (CMI) was suspected and a soybean formula was tried. The diarrhoea ceased. She began to gain weight but diarrhoea with overt blood recurred two weeks later. Soy protein intolerance was then suspected and the diet was altered to Nutramigen" (Mead Johnson & Co., Evansville, Indiana, USA), a casein hydrolysate formula. The stools again improved and bleeding stopped. Two weeks later, fresh blood reappeared in the stools without a change in consistency. Jejunal biopsy was normal. Barium swallow and follow-through were normal as was a Meckel scan. Proctoscopy showed a red, friable, mucosa at 4-7 cm, but the biopsy was normal. She was continuously fed Nutramigen and bleeding persisted. Her haemoglobin fluctuated between 95 and 112 g/l with elevated reticulocyte counts (2.6% to 6%). During the five months on Nutramigen, her appetite and weight gain were normal, there was no diarrhoea nor other signs of gastrointestinal intolerance apart from the presence of blood in her stools. Intolerance to Nutramigen was suspected and as a result, from the age of six months onwards, she was fed solely the elemental formula Vivonex" (Eaton Laboratories, Norwich, New York, USA). Within four days blood disappeared, but challenges with Nutramigen in the following weeks resulted in overt bleeding within 24 hours. In order to quantitate the intestinal blood loss following the administration of Nutramigen, radio-labelled erythrocytes were injected. Fig. 1 shows that both Nutramigen and cow's milk increased the intestinal blood loss. Patient 2 was breast fed 2 months and thereafter received Materna. At the age of three months he started to pass melaena. Brisk bleeding persisted and he required two blood transfusions a week. At emergency laparotomy there was a suspicion of a vascular malformation at the ileo-caecal junction and 20 cm of intestine was removed. The melaena persisted and as CMI was suspected the infant's formula was changed to Pregestimil" (Mead-Johnson Co). The stools became normal. After discharge he was again given the modified milk formula and at the age of seven months melaena reappeared. The infant was again given Pregestimil. This time, however, his condition did not improve and he was readmitted. He passed melaena during the first two days of his admission and his haemoglobin continued t o decline. Extensive investigations for the source of his bleeding were negative. Antinuclear factor was positive. Immunoglobulins A, G , and M were normal. Stool culture was negative. The possibility of an intolerance to the protein hydrolysate was considered and his diet changed to Vivonex. During the period following the change in the diet all stools were negative t o occult blood and stayed